During the past decade, Hospital Estadual Mario Covas conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 9 clinical trials were completed, i.e. on average, 69.2% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 9 clinical trials were completed. i.e. 225% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Estadual Mario Covas" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Janssen Research & Development, LLC" with 2 trials sponsored, "R-Pharm International, LLC" with 2 trials sponsored, "Apellis Pharmaceuticals, Inc." with 1 trials sponsored and "Genentech, Inc." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Estadual Mario Covas" #1 collaborator was "OCT Clinical Trials" with 2 trials as a collaborator, "Quintiles, Inc." with 2 trials as a collaborator, "BP - A Beneficência Portuguesa de São Paulo" with 1 trials as a collaborator, "Brazilian Research in Intensive Care Network (BRICNet)" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Estadual Mario Covas" are "Crohn Disease" (2 trials), "Rheumatoid Arthritis" (2 trials), "Ulcerative Colitis" (2 trials), "Acute B-Cell Lymphoblastic Leukaemia" (1 trials) and "Acute Respiratory Distress Syndrome" (1 trials). Many other conditions were trialed in "Hospital Estadual Mario Covas" in a lesser frequency.

Most popular intervention types in "Hospital Estadual Mario Covas" are "Drug" (12 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Etrolizumab" (4 trials), "7 day antibiotic course for VAT" (1 trials), "APL-9" (1 trials) and "Adalimumab 40mg q2w" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Estadual Mario Covas" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Estadual Mario Covas". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Hospital Estadual Mario Covas, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Estadual Mario Covas, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".